Novus Therapeutics, Inc. (17)

Browse by Contract Category

Contracts

Novus Therapeutics, Inc., 2020 Long Term Incentive Plan (Filed With SEC on March 31, 2021)
Description of Securities (Filed With SEC on March 31, 2021)
Open Market Sales Agreement by and between the Registrant and Jefferies, LLC dated March 30, 2021 (Filed With SEC on March 31, 2021)
Series X Exchange Agreement, dated December 31, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on January 7, 2021)
Executive Employment Agreement, dated March 15, 2021, between Eledon Pharmaceuticals, Inc. and Paul Little (Filed With SEC on March 31, 2021)
Executive Employment Agreement, dated March 1, 2021, between Eledon Pharmaceuticals, Inc. and Jon Kuwahara (Filed With SEC on March 31, 2021)
Executive Employment Agreement, dated September 9, 2020, between Novus Therapeutics, Inc. and David-Alexandre C. Gros, M.D (Filed With SEC on March 31, 2021)
Warrant Exchange Agreement, dated December 31, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on January 7, 2021)
Description of Securities (Filed With SEC on March 17, 2020)
Exchange Agreement, dated February 13, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on February 19, 2020)
Form of Warrant Exercise Agreement by and between Novus Therapeutics, Inc. and the Holders named therein (Filed With SEC on January 16, 2020)
Form of Private Placement Warrant (Filed With SEC on January 16, 2020)
Management Continuity Agreement, date August 7, 2017, between Novus Therapeutics, Inc. and Catherine C. Turkel (Filed With SEC on May 14, 2019)
Form of Securities Purchase Agreement, dated April 30, 2019, by and between Novus Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on May 2, 2019)
Form of Placement Agent Warrant (Filed With SEC on May 2, 2019)
Form of Warrant (Filed With SEC on May 2, 2019)
Executive Employment Agreement, dated November 10, 2015, between Otic Pharma, Inc. and Catherine C. Turkel (Filed With SEC on March 28, 2019)